7Baggers
 Revolution Medicines CEO Goldsmith sells $1.3 million in stock  Investing.com Sat, 15 Nov 2025 01:52:00 GMT
 Revolution Medicines stock hits all-time high at 66.02 USD By Investing.com  Investing.com Nigeria Fri, 14 Nov 2025 03:08:09 GMT
 Insider Sell: Jack Anders Sells 10,000 Shares of Revolution Medi  GuruFocus Fri, 14 Nov 2025 00:12:16 GMT
 revolution medicines stock hits all-time high at 66.02 usd  Investing.com India Thu, 13 Nov 2025 18:12:26 GMT
 Revolution Medicines CEO Goldsmith sells $1.8 million in stock By Investing.com  Investing.com Nigeria Thu, 13 Nov 2025 02:39:31 GMT
 research analysts issue forecasts for rvmd fy2025 earnings  MarketBeat Mon, 10 Nov 2025 07:22:58 GMT
 equities analysts issue forecasts for rvmd fy2025 earnings  MarketBeat Mon, 10 Nov 2025 07:22:50 GMT
 research analysts offer predictions for rvmd fy2025 earnings  MarketBeat Mon, 10 Nov 2025 07:10:28 GMT
 research analysts set expectations for rvmd fy2025 earnings  MarketBeat Mon, 10 Nov 2025 07:03:55 GMT
 why revolution medicines stock is gaining attention  TipRanks Fri, 07 Nov 2025 09:19:01 GMT
 revolution medicines’ q3 2025 earnings call highlights  TipRanks Fri, 07 Nov 2025 00:42:01 GMT
 revolution medicines stock hits all-time high at 62.48 usd  Investing.com Fri, 07 Nov 2025 00:31:31 GMT
 Does Revolution Medicines' Recent 27% Jump Reflect Its Real Value?  simplywall.st Thu, 06 Nov 2025 18:02:53 GMT
 revolution medicines stock hits all-time high at 62.48 usd by investing.com  Investing.com Australia Thu, 06 Nov 2025 14:59:23 GMT
 rvmd: hc wainwright & co. raises price target to $73, maintains  GuruFocus Thu, 06 Nov 2025 13:50:42 GMT
 revolution medicines (rvmd) gains optimism with price target boo  GuruFocus Thu, 06 Nov 2025 12:50:13 GMT
 td cowen maintains revolution medicines(rvmd.us) with buy rating  富途牛牛 Thu, 06 Nov 2025 12:18:05 GMT
 Revolution Medicines Posts Wider-Than-Expected Loss in Q3, Sales Nil  Yahoo Finance Thu, 06 Nov 2025 08:00:00 GMT
 Revolution Medicines’ Q3 2025 Earnings Call Highlights  TipRanks Thu, 06 Nov 2025 08:00:00 GMT
 revolution medicines reports q3 2025 financial results  TipRanks Thu, 06 Nov 2025 05:58:20 GMT
 decoding revolution medicines inc (rvmd): a strategic swot insig  GuruFocus Thu, 06 Nov 2025 05:09:22 GMT
 revolution medicines reports q3 eps ($1.61), consensus ($1.41)  TipRanks Thu, 06 Nov 2025 01:56:24 GMT
 revolution medicines (rvmd) earnings transcript  The Motley Fool Thu, 06 Nov 2025 00:21:00 GMT
 Revolution Medicines (RVMD) Earnings Transcript  The Motley Fool Wed, 05 Nov 2025 08:00:00 GMT

Revolution Medicines, Inc
(NASDAQ:RVMD) 

RVMD stock logo

Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gyne...

Founded: 2014
Full Time Employees: 117
CEO: Mark A. Goldsmith  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends